(Reuters) – British drugmaker GSK stated on Monday its vaccine, Priorix, was authorized by the U.S. Meals and DrugAdministration (FDA) for the prevention of measles, mumps and rubella for these aged one 12 months and above.

“We’re proud to make Priorix accessible within the U.S. for the primary time, including a alternative for suppliers to assist defend sufferers in opposition to these highly-contagious ailments,” GSK Head of U.S. Vaccines Judy Stewart stated.